Non-hodgkin's lymphoma in Saudi Arabia: Prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced disease

This publication has 27 references indexed in Scilit:

• Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACOD
  Annals of Internal Medicine, 1986
• Combination chemotherapy only for stage II non-Hodgkin's lymphoma
  European Journal of Cancer and Clinical Oncology, 1986
• MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma
  Annals of Internal Medicine, 1985
• Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP Chemotherapy
  Annals of Internal Medicine, 1983
• Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
  Journal of Clinical Oncology, 1983
• ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE
  The Lancet, 1975
• Criteria for Selection of a Subset Regression: Which One Should Be Used?
  Technometrics, 1972
• The effect of organic acids on renal clearance of methotrexate in man
  Clinical Pharmacology & Therapeutics, 1969
• A sarcoma involving the jaws in african children
  British Journal of Surgery, 1958
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958